Annual Drug Patent Expirations for TUDORZA+PRESSAIR Tudorza Pressair is a drug marketed by Covis and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for COVIS drug TUDORZA PRESSAIR appea…
New patent expiration for COVIS drug TUDORZA PRESSAIR Read Post »
Annual Drug Patent Expirations for HYSINGLA+ER Hysingla Er is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Purdue Pharma drug HYSINGLA ER appeared first…
New patent expiration for Purdue Pharma drug HYSINGLA ER Read Post »
Annual Drug Patent Expirations for NUCYNTA Nucynta is a drug marketed by Collegium Pharm Inc and is included in three NDAs. It is available from one supplier. There are eight…
The post New patent expiration for Collegium Pharm drug NUCYNTA appeared fir…
New patent expiration for Collegium Pharm drug NUCYNTA Read Post »
Annual Drug Patent Expirations for NUCYNTA+ER Nucynta Er is a drug marketed by Collegium Pharm Inc and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Collegium Pharm drug NUCYNTA ER appeared fi…
New patent expiration for Collegium Pharm drug NUCYNTA ER Read Post »
MACRILEN (macimorelin acetate) Novo Patent: 6,861,409 Expiration: Aug 1, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pate…
Drug Patent Expirations for the Week of July 31, 2022 Read Post »
Annual Drug Patent Expirations for MACRILEN Macrilen is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for NOVO drug MACRILEN appeared first on Dr…
Annual Drug Patent Expirations for ADDYI Addyi is a drug marketed by Sprout Pharms and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Sprout Pharms drug ADDYI appeared first on Drug…
New patent expiration for Sprout Pharms drug ADDYI Read Post »
MACRILEN (macimorelin acetate) Novo Patent: 6,861,409 Expiration: Aug 1, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pate…
Drug Patent Expirations for the Week of July 31, 2022 Read Post »
Annual Drug Patent Expirations for EVAMIST Evamist is a drug marketed by Padagis Us and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Padagis Us drug EVAMIST appeared first on DrugPat…
New patent expiration for Padagis Us drug EVAMIST Read Post »
Annual Drug Patent Expirations for BEYAZ Beyaz is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for Bayer Hlthcare drug BEYAZ appeared first on …
New patent expiration for Bayer Hlthcare drug BEYAZ Read Post »